All Stories

  1. 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
  2. 2022: Position of Brazilian Diabetes Society on exercise recommendations for people with type 1 and type 2 diabetes
  3. The 2021–2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice
  4. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
  5. Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance
  6. Dipeptidyl peptidase 4 (DPP4), adipose inflammation, and insulin resistance: is it time to look to the hepatocyte?
  7. Constitutive DPP4 activity, inflammation, and microvascular reactivity in subjects with excess body weight and without diabetes
  8. Diabetes Care in Brazil
  9. Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
  10. Efeito da perda ponderal induzida pela cirurgia bariátrica sobre a prevalência de síndrome metabólica